What is Integra Lifesciences Holdings Gross-Profit-to-Asset %?
Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Integra Lifesciences Holdings's annualizedGross Profit for the quarter that ended in Dec. 2023 was $906 Mil.
Integra Lifesciences Holdings's average Total Assets over the quarter that ended in Dec. 2023 was $3,761 Mil. Therefore, Integra Lifesciences Holdings's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 24.09%.
Integra Lifesciences Holdings Gross-Profit-to-Asset % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Integra Lifesciences Holdings's Gross-Profit-to-Asset %
For the Medical Devices subindustry, Integra Lifesciences Holdings's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integra Lifesciences Holdings's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Integra Lifesciences Holdings's Gross-Profit-to-Asset % distribution charts can be found below:
* The bar in red indicates where Integra Lifesciences Holdings's Gross-Profit-to-Asset % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Gross Profit data used here is four times the quarterly (Dec. 2023) data.
Gross-Profit-to-Asset % is displayed in the 30-year financial page.
Integra Lifesciences Holdings Gross-Profit-to-Asset % Related Terms
Thank you for viewing the detailed overview of Integra Lifesciences Holdings's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.
Integra Lifesciences Holdings (Integra Lifesciences Holdings) Business Description
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman specialty surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IART has been successfully added to your 